Amyloid β protein in skin of patients with amyotrophic lateral sclerosis

Lancet

Volumn 351, Issue 9107, 1998, Pages 956-957

  Ono, Seiitsu ^a   Matsuno, Sayoko ^a   Shimizu, Natsue ^a   Shoji, Shim'ichi ^a   Tamaoka, Akira ^a,b  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0032495652     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60610-1     Document Type: Article

References (5)

1. 1 Kolde G, Bachus R, Ludolph A. Skin involvement in amyotrophic lateral sclerosis. Lancet 1996, 347: 1226-27.
2. 2 Joachim CL, Mori H, Selkoe DJ. Amyloid β-protein deposition in tissue other than brain in Alzheimer's disease. Nature 1989; 341: 226-30.
3. 3 Tamaoka A, Sawamura N, Odaka A, et al. Amyloid β protein 1-42/43 (Aβ 1-42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study. J Neurol Sci 1995; 679: 151-56.
4. 4 Suzuki N, Cheung TT, Cai XD, et al. An increased pecentage of long amyloid β protein secreted by familial amyloid β protein precursor (β APP717) mutants. Science 1994; 1336-40.
5. 5 Wen GY, Wisniewski HM, Blondal H, et al. Presence of non-fibrillar amyloid β protein in skin biopsies of Alzheimer's disease (AD), Down's syndrome and non-AD normal persons. Acta Neuropathol 1994; 88: 201-06.